Rip2 kinase catalytic domain (1 - 310) complex with sb-203580 Deposition Author(s): Bertin, J. , Bridges, A. , Casillas, L. , Charnley, A.K. , Convery, M.A. , Gough, P.J. , Hardwicke, P. , Jones, E. , Lakdawala Shah, A. , Marquis, R.W. , Votta, B.J.
Date: 2015-09-24 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Homo Sapiens Sequences Data: 5AR4_A , 5AR4_B
Rip2 kinase catalytic domain (1 - 310) complex with benzimidazole Deposition Author(s): Bertin, J. , Bridges, A. , Casillas, L. , Charnley, A.K. , Convery, M.A. , Gough, P.J. , Hardwicke, P. , Jones, E. , Lakdawala Shah, A. , Marquis, R.W. , Votta, B.J.
Date: 2015-09-24 Method: X-RAY DIFFRACTION Resolution: 2.66 Å Organism(s): Homo Sapiens Sequences Data: 5AR5_A , 5AR5_B
Rip2 kinase catalytic domain (1 - 310) complex with biaryl urea Deposition Author(s): Bertin, J. , Bridges, A. , Casillas, L. , Charnley, A.K. , Convery, M.A. , Gough, P.J. , Hardwicke, P. , Jones, E. , Lakdawala Shah, A. , Marquis, R.W. , Votta, B.J.
Date: 2015-09-24 Method: X-RAY DIFFRACTION Resolution: 2.71 Å Organism(s): Homo Sapiens Sequences Data: 5AR7_A , 5AR7_B
Rip2 kinase catalytic domain (1 - 310) complex with biphenylsulfonamide Deposition Author(s): Bertin, J. , Bridges, A. , Casillas, L. , Charnley, A.K. , Convery, M.A. , Gough, P.J. , Hardwicke, P. , Jones, E. , Lakdawala Shah, A. , Marquis, R.W. , Votta, B.J.
Date: 2015-09-24 Method: X-RAY DIFFRACTION Resolution: 2.79 Å Organism(s): Homo Sapiens Sequences Data: 5AR8_A , 5AR8_B
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, compound 3 complex Deposition Author(s): Casillas, L.N. , Convery, M.A. , Haile, P.A. , Lakdawala, A.S. , Votta, B.J.
Date: 2016-04-06 Method: X-RAY DIFFRACTION Resolution: 2.69 Å Organism(s): Homo Sapiens Sequences Data: 5J79_A , 5J79_B
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, gsk583 complex Deposition Author(s): Casillas, L.N. , Convery, M.A. , Haile, P.A. , Lakdawala, A.S. , Votta, B.J.
Date: 2016-04-06 Method: X-RAY DIFFRACTION Resolution: 2.53 Å Organism(s): Homo Sapiens Sequences Data: 5J7B_A , 5J7B_B
Ms2 protein capsid/rna complex Deposition Author(s): Adams, C.J. , Convery, M.A. , Ellington, A.D. , Hirao, I. , Peabody, D.S. , Phillips, S.E.V. , Rowsell, S. , Stockley, P.G. , Stonehouse, N.J.
Date: 1998-05-15 Method: X-RAY DIFFRACTION Resolution: 2.8 Å Organism(s): Enterobacterio Phage Ms2 , Synthetic Construct Sequences Data: 5MSF_R , 5MSF_S , 5MSF_A , 5MSF_B , 5MSF_C
Fab complex with grobeta. abvance: increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. Deposition Author(s): Convery, M.A. , Ward, P. , Zhao, B.
Date: 2017-06-26 Method: X-RAY DIFFRACTION Resolution: 1.65 Å Organism(s): Homo Sapiens Sequences Data: 5OB5_A , 5OB5_H , 5OB5_L
Fab. abvance: increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. Deposition Author(s): Convery, M.A. , Vicentini, G.
Date: 2017-06-26 Method: X-RAY DIFFRACTION Resolution: 1.92 Å Organism(s): Mus Musculus Sequences Data: 5OBF_H , 5OBF_L
Inha (t2a mutant) complexed with (4-((1h-pyrazol-1-yl)methyl)phenyl)methanol Deposition Author(s): Convery, M.A.
Date: 2017-07-18 Method: X-RAY DIFFRACTION Resolution: 1.87 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 5OIC_A